Medicare Enrolled
Dr. Douglas Hutt, MD
Critical Care Medicine · East Brunswick, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hutt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hutt?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hutt
Dr. Douglas Hutt is a critical care medicine specialist in East Brunswick, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hutt performed 3,196 Medicare services across 1,717 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hutt received a total of $6,751 from 44 pharmaceutical and/or device companies across 440 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hutt is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 14% volume in NJ
$6,751 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,196
Medicare services
Top 14% in NJ for critical care medicine
1,717
Unique beneficiaries
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~168 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,384 | $109 | $478 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
354 | $103 | $440 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
215 | $47 | $167 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
174 | $185 | $1,160 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
140 | $24 | $132 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
137 | $66 | $319 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
136 | $50 | $223 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
134 | $53 | $232 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
126 | $50 | $120 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
108 | $34 | $91 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
106 | $72 | $175 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
59 | $145 | $697 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
41 | $152 | $868 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
37 | $72 | $293 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
27 | $35 | $211 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
18 | $93 | $476 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,751
Total received (2018-2024)
Avg $964/year across 7 years
Top 16% in NJ for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
440
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,597 (97.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$154 (2.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,265
2023
$1,243
2022
$1,058
2021
$334
2020
$354
2019
$1,385
2018
$1,113
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$186
GlaxoSmithKline, LLC.
$161
Philips North America LLC
$150
Genentech USA, Inc.
$139
GENZYME CORPORATION
$112
Insmed, Inc.
$100
CSL Behring
$82
Mylan Specialty L.P.
$68
Regeneron Healthcare Solutions, Inc.
$63
Grifols USA, LLC
$45
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
Amgen Inc.
$30
SANOFI-AVENTIS U.S. LLC
$21
Merck Sharp & Dohme LLC
$17
Axsome Therapeutics, Inc.
$16
Novartis Pharmaceuticals Corporation
$15
Bayer Healthcare Pharmaceuticals Inc.
$14
Optinose US, Inc.
$13
Top 3 companies account for 39.3% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,220
AstraZeneca Pharmaceuticals LP
$797
Genentech USA, Inc.
$495
GENZYME CORPORATION
$460
Boehringer Ingelheim Pharmaceuticals, Inc.
$443
Mylan Specialty L.P.
$400
Novartis Pharmaceuticals Corporation
$310
CSL Behring
$283
Insmed, Inc.
$269
Regeneron Healthcare Solutions, Inc.
$260
Philips Electronics North America Corporation
$197
Sunovion Pharmaceuticals Inc.
$178
Amgen Inc.
$157
Philips North America LLC
$150
E.R. Squibb & Sons, L.L.C.
$107
Mallinckrodt Hospital Products Inc.
$102
Grifols USA, LLC
$97
Takeda Pharmaceuticals U.S.A., Inc.
$97
Electromed, Inc.
$87
Axsome Therapeutics, Inc.
$81
Shire North American Group Inc
$78
Astellas Pharma US Inc
$62
Merck Sharp & Dohme LLC
$33
Actelion Pharmaceuticals US, Inc.
$29
Inogen, Inc.
$29
ADVANCED RESPIRATORY, INC
$28
Mallinckrodt Enterprises LLC
$28
PFIZER INC.
$27
Janssen Pharmaceuticals, Inc
$27
Bayer HealthCare Pharmaceuticals Inc.
$23
SANOFI-AVENTIS U.S. LLC
$21
Resmed Corp
$18
Merck Sharp & Dohme Corporation
$15
Harmony Biosciences LLC
$14
SANOFI PASTEUR INC.
$14
Bayer Healthcare Pharmaceuticals Inc.
$14
Nabriva Therapeutics, plc
$14
Sanofi Pasteur Inc.
$13
Optinose US, Inc.
$13
United Therapeutics Corporation
$13
HARMONY BIOSCIENCES LLC
$13
La Jolla Pharmaceutical Company
$13
Teva Pharmaceuticals USA, Inc.
$12
Mitsubishi Tanabe Pharma America, Inc.
$12
Top 3 companies account for 37.2% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ARALAST · Adempas · Arikayce · Astral · BEVESPI AEROSPHERE · BREO · BREZTRI · BROVANA · CHANTIX · CRESEMBA · CUVITRU · DIFICID · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · ELIQUIS · Esbriet · FASENRA · FLUZONE HIGH-DOSE · GIAPREZA · GLASSIA · Hizentra · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · JARDIANCE · LONHALA MAGNAIR · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Prolastin-C Liquid · REZUROCK · Radicava · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · The Vest System Model 105 Home Care · UTIBRON NEOHALER · Utibron · Wakix · XARELTO · XOLAIR · Xembify · Xenleta · Xhance · Xolair · YUPELRI · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Critical care medicines within 10 mi
95
Per 100K population
11.0
County median income
$109,028
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL
4.0 mi
4.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hutt is a clinical cardiology specialist, with above-average Medicare volume (top 14% in NJ), with low-engagement industry engagement in the top 16% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hutt experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Hutt performed 1,384 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hutt receive payments from pharmaceutical companies?
Yes. Dr. Hutt received a total of $6,751 from 44 companies across 440 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hutt's costs compare to other critical care medicines in East Brunswick?
Dr. Hutt's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hutt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in East Brunswick
Browse critical care medicines in East Brunswick ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in NJ
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in NJ
Which NJ critical care medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology